Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
[google_news title=”” keyword=”Shortages of life-saving drugs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Shortages of life-saving drugs
- Mark Cuban says Cost Plus Drugs targeting generic meds in short supply as it opens manufacturing facilityon March 4, 2024 at 2:00 pm
"Cost Plus Drugs is proudly bringing pharmaceutical manufacturing back to the U.S. with advanced robotic and AI computer vision technology that allows us to pivot for making one drug type to another ...
- Drug Shortages in the US: Causes and What the FDA Is Doing to Prevent New Shortageson March 3, 2024 at 4:00 pm
Drug shortages range from something as simple as buffered aspirin to life-saving medications such as cancer chemotherapy agents, antibiotics, and emergency medications such as epinephrine.
- Let’s preserve access to life-saving medicationson March 1, 2024 at 7:56 am
MinnPost is a nonprofit newsroom that relies on the support of readers to remain free for all to access — no paywall or subscriptions. Will you help us keep it this way by supporting our newsroom with ...
- Patients across the country say they STILL can't get life saving drugs a week after cyberattack by 'foreign nation' on America's biggest health insureron February 28, 2024 at 11:50 am
The debacle also comes as the US battles historic shortages of lifesaving drugs like chemotherapy and antibiotics. Julie Gregory of Ohio just started oral chemotherapy last week for stage three cancer ...
- Patients Wait for Lifesaving Medications as US Drug Shortage Continueson February 15, 2024 at 10:25 pm
Patients all around the world are still experiencing drug shortages long after COVID-19 supply-chain jams have cleared. The U.S. Senate is looking at solutions as a nonprofit steps in to find ...
- Patients Wait for Life-Saving Medicationson February 15, 2024 at 10:00 pm
With her MBA and background as a college business professor, Bray founded Angels for Change a Florida-based organization that is the only patient-centered nonprofit set up to end drug shortages.
- US health agencies launch probe into generic drug shortages that are 'endangering' Americans - as doctors reveal they're forced to choose who lives and who dieson February 15, 2024 at 9:33 am
The number of drugs with shortages has reached an-time high, forcing patients with cancer and chronic diseases to choose between facing more than a year's wait for their life-saving medications or ...
- How Stock Outs Or Shortages Affect Private Healthcare And Consumerson February 3, 2024 at 8:00 am
How do stock outs or shortages in public health facilities ... Many of these are life saving drugs. However, in the low and middle-income countries, “stock outs” of these medicines are very ...
- Doctors concerned over shortage of life-saving chemotherapy drugson July 5, 2023 at 2:15 pm
RELATED: Chemotherapy shortages push cancer centers toward ... to other treatment options due to a shortage of life-saving chemotherapy drugs. “The demand for cancer (treatment) unfortunately ...
- Shortage of life-saving chemo drugs worries doctorson July 5, 2023 at 1:31 pm
Doctors are now having to make difficult decisions of turning to other treatment options due to a shortage of life-saving chemotherapy drugs. Documents: Pattern of inappropriate behavior led ...
via Bing News